GLP-1 coverage cuts: What shifting payer policies mean for prescribing, access, and utilization Feb 18th, 2026 Glucagon-like peptide-1 (GLP-1) receptor agonists like semaglutide (sold under brandnames Wegovy and Ozempic) and tirzepatide (Zepbound, Mounjaro) have transformed how physicians and patients approach treatment for type 2 diabetes and obesity
Based on her health-plan documents, she figured insurance wouldn't cover the drug because she isn't diabetic
Then the solution going in can hurt too
Thats because when the body experiences physical stress, including losing weight quickly, more hairs can shift into a resting phase and fall out a few months later typically two to three months after the event, Rossi explains
Nausea has been reported as very common in GLP-1 patients (more than 1 in 10), and constipation has been reported as common in these patients (more than 1 in 100) [4]
In some embodiments, the otic formulation or composition comprises between about 1% to about 3% by weight of the therapeutic agent, or pharmaceutically acceptable prodrug or salt thereof